Edwards Lifesciences Corporation (Edwards Lifesciences) operates as a global structural heart innovation company, driven by a passion to improve patient lives.
The company conducts operations worldwide and is managed in the following geographical re…
Analysis
Hope premium
Edwards Lifesciences Corporation carries what we call a hope premium: an average business trading at an ambitious price. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is expensive. You pay 49.8× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 18% yearly growth; analysts expect 12%. The gap between price and consensus is worth watching: demanding expectations.
The trajectory is moderate and the balance sheet is sturdy. The company scores 14/20 on our value-creation score: strong value creator.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202372
83
2023202420252026
All-time high
90
Dec 2025
All-time low
12
Oct 2024
Average rank
59
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
24
13
18
9
Price/Earnings
16
29
34
27
Price/Book
35
43
16
19
Dividend Yield
1
1
1
1
Value (overall)
8
12
15
10
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.